August 8, 2008
A Raw Deal, in a Researcher's Eyes
Dispute over an invention highlights problems in technology transfer
The University of Georgia and a former faculty member there stand to make some $70-million from a license on an invention used for the popular eyedrops Restasis, sold by Allergan Inc.
Sound great? Not to Renee L. Kaswan, the former professor of veterinary medicine who for more than a decade has been prodding the institution to be more aggressive in commercializing the invention.
She contends the university would be entitled to substantially more — as much as
This content is only for subscribers. You can gain access by purchasing a:
Print Subscription
Digital Subscription
Already have an account? Log In Now.
-
The Chronicle Review
-
Government
-
Advice
